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essential to preserve ventricular and pulmonary vascu-
lar function, reduce arrhythmias, and improve flow
dynamics in the Fontan circuit. Among the modifica-
tions of the Fontan operation currently used, the extra-
cardiac conduit approach may offer the greatest poten-
tial for optimizing early postoperative outcomes.
Since 1992, we have used the extracardiac conduit
Fontan procedure as our operation of choice for pallia-
tion in patients with single ventricle physiology. In this
report, we present our initial experience with this tech-
nique, with a focus on our early postoperative results.
Patients and methods
Demographic and diagnostic information. Between July
1992 and April 1997, 51 consecutive patients underwent total
cavopulmonary anastomosis with an extracardiac conduit at the
University of California, San Francisco (UCSF). Although we
currently operate at 3 hospitals, all Fontan operations during the
study period were performed at the UCSF Medical Center. This
excludes an additional 8 patients who had a previous atriopul-
F ollow-up studies have shown that although outcomeshave improved substantially over time, results of the
Fontan operation and its modifications remain subopti-
mal.1-4 The instantaneous hazard for Fontan failure is
greatest in the first month after the operation,1,4 a fact
that underscores the importance of early results for the
overall success of a program for univentricular pallia-
tion. For perioperative results to be optimized, it is
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monary or atrioventricular Fontan connection revised to an
extracardiac conduit Fontan during the same period.5
Median age was 4.9 years (1.5-44 years) and median
weight was 16 kg (10-68 kg). Primary diagnoses are summa-
rized in Table I. The morphologic characteristics of the dom-
inant ventricle were those of the left venticle in 33 patients,
the right ventircle in 11, and indeterminate in 4. Both the right
and left ventricles were present in 3 patients. Twenty-five
patients (49%) had anatomy other than tricuspid atresia or
double-inlet left ventricle. All but 2 patients had undergone
prior operations (median 2, range 0-7), which are summa-
rized in Table II. Median age at the time of the first shunt or
band procedure was 24 days (1 day–24 years) and at con-
struction of the classic or bidirectional Glenn procedure, 2.5
years (2 months–42 years).
At the time of Fontan completion, pulmonary blood flow
was supplied by a Glenn anastomosis only in 13 patients, by
a Glenn anastomosis plus another source in 33, and by anoth-
er source only in 5. All patients had undergone preoperative
echocardiography and catheterization. Results of these stud-
ies are summarized in Table III. Aortopulmonary collaterals
were present at preoperative catheterization in 15 patients,
and in 5 they were occluded by coil embolization. No patient
had significant semilunar valvular regurgitation, and 2
patients had subvalvular systemic outflow tract obstruction.
Operative techniques. Through a standard median ster-
notomy, a modified Fontan circulation was completed by con-
necting the inferior vena cava to the pulmonary arteries with
an extracardiac conduit of either expanded polytetrafluo-
roethylene or aortic allograft. The operative strategy centered
on preservation of ventricular and pulmonary vascular func-
tion. Unless a concomitant intracardiac procedure was to be
performed, aortic crossclamping was avoided. No active cool-
ing was used and the operation was performed on a warm
beating heart. Hemodilution was avoided by the use of a
blood prime in the cardiopulmonary bypass (CPB) circuit,
and the priming solution was supplemented with calcium to
optimize cardiac function.
Every effort was made to avoid or minimize the duration of
total CPB. If the pulmonary arteries were large enough and
did not require extensive augmentation, the pulmonary anas-
tomosis was performed off bypass with the use of vascular
clamps so that the Glenn shunt perfused one or both lungs.
With this technique the duration of CPB was limited to the
time required to perform the inferior cavopulmonary anasto-
mosis only. When bypass was established, it was in the form
of partial support with inferior vena cava cannulation alone
whenever possible. 
After the patients were weaned from CPB, Fontan hemo-
dynamics were evaluated. If the Fontan pressure was 18 mm
Hg or more with a transpulmonary gradient of 10 mm Hg or
more, consideration was given to placement of a fenestration
between the conduit and the right atrial free wall. This was
accomplished without return to CPB either with a direct side-
to-side anastomosis or with a 4-8 mm polytetrafluoroethylene
tube graft along with a snare device. Aprotinin and modified
ultrafiltration were not used.
Data analysis. Data were collected on retrospective review
of patient records. The early postoperative period was defined
as the time period before hospital discharge or as 30 days
after the operation if discharge occurred earlier. After dis-
charge, all patients were followed up for at least 6 months.
Median follow-up time was 1.9 years (6 months–3.8 years).
Continuous variables before and after the Fontan operation or
between 2 groups of patients were compared with the use of
the paired or independent samples t test, respectively.
Dichotomous variables were compared by means of Fisher’s
Table I. Anatomic diagnoses
Primary diagnosis No. of patients
Tricuspid atresia 13
Double-inlet left ventricle 13
Atrial isomerism/heterotaxy 6
Pulmonary atresia with intact ventricular septum 4
Hypoplastic left heart syndrome 2
Other complex functional single ventricle 13
Table II. Previous procedures
Patients
Previous procedure No. %
Bidirectional Glenn anastomosis 42 82*
Systemic–pulmonary arterial shunt 35 69†
Atrial septectomy 26 51
Pulmonary arterial reconstruction 22 43
Ligation of pulmonary trunk 15 29
Relief of systemic outflow tract obstruction 11 22
Pulmonary arterial band 9 18†
Classic Glenn anastomosis 6 12*
Atrioventricular valve repair 4 8
*Two patients had previously undergone both classic and bidirectional Glenn
procedures. 
†Two patients had previously undergone both systemic–pulmonary arterial
shunt and pulmonary arterial band.
Table III. Preoperative hemodynamics and echocar-
diographic findings
Variable Value
Mean systemic arterial blood pressure (mm Hg) 80.0 ± 11.8
Mean pulmonary arterial pressure (mm Hg) 12.1 ± 5.2
Common atrial pressure (mm Hg) 4.3 ± 2.3
Transpulmonary pressure gradient (mm Hg) 7.6 ± 4.8
Ventricular end-diastolic pressure (mm Hg) 6.8 ± 2.7
Pulmonary vascular resistance (Wood units) 2.3 ± 1.2
Pulmonary/systemic blood flow ratio 1.1 ± 0.8
Systemic arterial oxygen saturation (%) 83.1 ± 5.2
Atrioventricular valve regurgitation ‡ mild 6 (12%)
(No. of patients)
Data are expressed as mean ± standard deviation or number and percent of
patients.
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exact test or c 2 analysis. Correlation between 2 continuous
variables was assessed with linear regression analysis. 
Because only 1 death and only 1 Fontan failure occurred
during the study period, these variables could not be used to
analyze outcome. Instead, outcome measures assessed
included the following variables: duration of mechanical ven-
tilatory support (continuous and longer than/shorter than 24
hours), duration of inotropic support (continuous and longer
than/shorter than 3 days), occurrence of arrhythmias, dura-
tion of stay in the intensive care unit (continuous and longer
than/shorter than 7 days), duration of chest tube drainage
(continuous and longer than/shorter than 14 days), and dura-
tion of hospital stay (continuous and longer than/shorter than
21 days). 
Independent variables analyzed included the following:
date of the operation, age, weight, ventricular morphology,
morphology other than tricuspid atresia or double-inlet left
ventricle, duration of systemic–pulmonary arterial shunting
or pulmonary arterial banding, prior bidirectional cavopul-
monary anastomosis, duration of cavopulmonary anastomo-
sis, preoperative hemodynamics and atrioventricular valve
function, presence of aortopulmonary collateral arteries,
duration of CPB, use of cardioplegic arrest, conduit type,
conduit size, Fontan fenestration, and additional operative
procedures at the time of the Fontan completion. 
SPSS for Windows 6.1 (SPSS Inc, Chicago, Ill) was used
for statistical analysis. Data are expressed as mean ± standard
deviation or median (range). Odds ratios (OR) are presented
with 95% confidence intervals (CI).
Results
Perioperative data. A nonringed polytetrafluoroeth-
ylene graft was used to complete the extracardiac
Fontan operation in 42 patients; a cryopreserved aortic
allograft was used in 7 and direct anastomosis between
the pulmonary trunk and the inferior vena cava was
performed in 2. The median conduit size was 20 mm
(16-25 mm). Pulmonary arterial augmentation was per-
formed in 30 patients, ligation of the pulmonary trunk
in 21, and bidirectional superior cavopulmonary anas-
tomosis in 5. Intracardiac procedures were performed
in 5 patients (10%), all of whom were among the first
25 patients in the series. These procedures included
enlargement of the bulboventricular foramen in 2, atrio-
ventricular valvuloplasty in 2, and ablation of an
ectopic atrial focus in 1. 
Median CPB time (including periods of partial CPB
in 14 patients) was 92 minutes (66-247 minutes) and
decreased significantly over the course of our experi-
ence (r = –0.38, P = .006). Cardioplegic arrest with
aortic crossclamping was used in only 11 patients
(22%), all of whom were operated on before 1995. In
these 11 patients, crossclamp time ranged from 7 to 66
minutes (median 39 minutes). 
A fenestration was performed during the operation in
24 patients (47%). In the early postoperative period, 6
additional patients underwent either placement of a
new fenestration or revision of a previous fenestration.
Postoperative fenestrations and revisions were per-
formed as closed procedures in the intensive care unit
without the need to return to the operating room.
Twenty-seven patients (53%) were discharged home
with a fenestration. There was a marked decrease in the
incidence of fenestration over time, with only 4 of the
last 20 patients (20%) undergoing a fenestration com-
pared with 20 of the first 31 patients (65%; P = .02). 
Early survival and morbidity. There were no early
deaths. Fontan failure occurred in 1 patient who was a
poor candidate for the Fontan operation. This was a 40-
year-old man with tricuspid atresia, severe right pul-
monary arterial hypertension, and proximal occlusion
caused by complications of previous shunts, systemic
hypertension, and scoliosis resulting in ventilatory prob-
lems. Owing to limited therapeutic options and severe
symptomatic cyanosis, he elected to undergo a one-lung
Fontan operation. Systemic hypotension developed as a
result of diastolic ventricular dysfunction (atrial pressure
of 10 mm Hg) and elevated Fontan pressure of 22 mm
Hg. The Fontan conduit was taken down and a sys-
temic–pulmonary artery shunt was re-established.
Five patients (10%) had new transient early postop-
erative supraventricular tachyarrhythmias, including
junctional ectopic tachycardia in 4 and atrial flutter in
1. In 3 of these patients the tachyarrhythmia was limit-
ed to the first 48 hours after the operation, and in 2 it
was very brief, lasting less than 10 minutes. None of
the patients were discharged on a program of antiar-
rhythmia medication. After discharge, arrhythmia
recurred 20 months later in the patient with atrial flut-
ter. New transient sinus node dysfunction necessitating
temporary pacing occurred in 4 patients (8%) in the
early postoperative period. None of the patients
required a permanent pacer at the time of hospital dis-
charge. In 3 of the patients, sinus rhythm returned with-
in the first 48 hours after the operation. The fourth
patient required temporary pacing for several days but
eventually returned to normal sinus rhythm. A Holter
monitor used before discharge showed no abnormali-
ties. Recurrent sinus node dysfunction eventually
developed in this patient, necessitating a permanent
pacemaker 3.5 years after discharge. New permanent
complete heart block necessitating a pacemaker
occurred in 1 patient who underwent enlargement of
the bulboventricular foramen ovale. Ventricular tachy-
cardia occurred in 2 patients. In 1 patient it was related
to severe hemodynamic compromise caused by mal-
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functioning of a previously placed ventricular pace-
maker. The second patient developed nonsustained
asymptomatic recurrent ventricular tachycardia. Electro-
physiologic study showed no inducibility and he was
discharged to his home receiving no medications. He
was subsequently readmitted 2 months later with an-
other episode of ventricular tachycardia, which was
controlled medically. 
Other transient early postoperative complications
included elevated liver enzyme levels in 8 patients,
renal failure in 4, diaphragmatic paresis without the
need for plication in 3, and cardiac tamponade in 2.
Forty-two patients (82%) were discharged on a regimen
of either oral anticoagulation (n = 24) or antiplatelet (n
= 18) medications.
Postoperative hemodynamics and resource use.
The median Fontan pressure and transpulmonary gradi-
ent were low and did not change significantly between
the operating room and the first postoperative day
(Table IV). Early postoperative outcome variables are
outlined in Table V. Median duration of chest tube
drainage was 8 days (range 3-210 days), and prolonged
chest tube drainage (>14 days) occurred in 11 patients
(21%). Duration of chest tube drainage did not correlate
with any hemodynamic or operative variables including
preoperative pulmonary vascular resistance, postopera-
tive Fontan pressure, or the incidence of fenestration. 
Factors associated with extended resource use are
summarized below. Prolonged mechanical ventilatory
support (>24 hours) was associated with longer dura-
tion of CPB (145 ± 54 vs 107 ± 42 minutes, P = .02).
Factors associated with prolonged inotropic support
(>3 days) included longer duration of CPB (142 ± 61 vs
102 ± 33 minutes, P = .006) and higher Fontan pressure
(15.0 ± 2.8 vs 13.0 ± 2.2 mm Hg, P = .01). 
Hemodynamic and operative variables associated
with prolonged postoperative stay in the intensive care
unit (>7 days) included higher preoperative pulmonary
arterial pressure (15.1 ± 6.9 vs 11.1 ± 4.3 mm Hg, P =
.02), surgery with aortic crossclamping (OR = 3.7, 95%
CI = 1.4-9.5, P = .02), and higher postoperative Fontan
pressure (15.5 ± 2.8 vs 13.2 ± 2.2 mm Hg, P = .009).
Factors associated with prolonged hospital stay (>21
days) included higher preoperative transpulmonary
pressure gradient (10.0 ± 7.0 vs 6.5 ± 3.4 mm Hg, P =
.04) and higher postoperative Fontan pressure (15.9 ±
2.2 vs 12.8 ± 2.1 mm Hg, P = .006). 
Outcomes after hospital discharge. Room air oxy-
gen saturation increased from a preoperative median
level of 83% (73%-93%) to 95% (85%-99%) on post-
operative follow-up. Patients with lower saturations
were those whose fenestration remained open. Five
patients underwent elective fenestration closure with
the previously implanted snare device an average of 10
months after the Fontan operation. In 3 patients the fen-
estration was documented to have closed spontaneously.
All surviving patients were in New York Heart Associ-
ation class I (82%) or II (16%) except 1 patient who was
in class III. This was a patient who had been converted
to a one-lung Fontan circulation after thrombosis and
occlusion of the left pulmonary artery. None of the
patients showed evidence of conduit stenosis or throm-
bosis on follow-up echocardiogram. One patient had a
cerebrovascular accident 12 months after the operation.
This patient had undergone a fenestrated Fontan proce-
dure and was discharged receiving an antiplatelet agent
only. His fenestration was found to be occluded on
echocardiogram. He was started on a regimen of antico-
agulant therapy and the neurologic deficit subsequently
cleared. Late atrial dysrhythmias occurred in 2 patients.
One patient presented with recurrent atrial flutter 20
months after discharge and he was treated medically.
The second patient developed recurrent sinus node dys-
function requiring a permanent pacemaker implantation
3.5 years after the Fontan operation. Recurrent ventric-
ular tachycardia occurred 2 months after discharge in 1
patient who was treated medically. Protein-losing enter-
opathy developed in 1 patient and was managed effec-
tively with medical therapy. One patient required mitral
valve replacement 3.5 years after the Fontan operation
for worsening regurgitation. Two patients were readmit-
ted 22 and 54 days after the operation for drainage of
recurrent pleural effusions. The second of these patients
underwent resternotomy 5 months after the Fontan pro-




Pulmonary artery/Fontan pressure* 13.7 ± 2.6 12.9 ± 2.8
Transpulmonary pressure gradient 8.3 ± 2.6 7.7 ± 2.4
Common atrial pressure 5.2 ± 2.2 5.3 ± 2.5
*All pressures are expressed in millimeters of mercury ± standard deviation.
Table V. Early postoperative outcome variables
Variable Value
Mechanical ventilatory support (h) 16 (1-580)
Inotropic support (d) 1.8 (1-11)
Chest tube drainage (d) 8 (3-210)
Intensive care unit stay (d) 4 (1-46)
Hospital stay (d) 13 (6-59)
Data are presented as median (range).
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cedure for fenestration of the extracardiac conduit for
attempted treatment of persistent effusions. Massive
bleeding occurred during this procedure, and the patient
died of a cardiac arrest. Actuarial freedom from death or
Fontan failure was 96%.
Discussion
The Fontan circulation has marginal hemodynamics,
and during the vulnerable early postoperative period, it
is at greatest risk for Fontan failure and associated com-
plications. Small disturbances in ventricular or pul-
monary vascular function, development of arrhythmias,
or turbulent flow in the Fontan circuit translate into ele-
vated Fontan pressure and poor outcome. To optimize
perioperative results it is essential to preserve ventricu-
lar and pulmonary vascular function, reduce arrhyth-
mias, and improve flow dynamics in the Fontan circuit. 
Outcomes with the lateral tunnel technique have been
improving, and several centers have reported encourag-
ing results.3,4,6-8 Nevertheless, among the modifications
of the Fontan operation currently used, the extracardiac
conduit approach may offer the greatest potential for
optimizing early postoperative outcomes. The strategy
we have used in approaching the Fontan operation has
been primarily aimed at optimizing perioperative ven-
tricular and pulmonary vascular function. This requires
not only intraoperative and technical measures, but pre-
operative planning as well. 
An important preoperative strategy is to perform
early bidirectional Glenn anastomosis to preserve ven-
tricular function by relieving the volume load on the
single ventricle.9-12 Most of the patients included in this
study have undergone previous palliation elsewhere,
and their preoperative status was not optimized with
early staging to a bidirectional Glenn shunt, as is our
preferred approach. Whereas the median age among
160 patients undergoing a bidirectional Glenn shunt at
our institution since 1990 was 7.8 months, the median
age at which our Fontan cohort underwent a bidirec-
tional Glenn shunt was significantly higher at 2.5 years.
As more of our patients reach the age for a Fontan pro-
cedure after early volume unloading with a bidirection-
al Glenn anastomosis, we expect to appreciate better
the advantages of this strategy on Fontan outcome.
Another important preoperative strategy relates to the
use of cardioplegic arrest and the duration of CPB in
the Fontan operation. Prolonged cardioplegic arrest and
CPB times are associated with increased risk of early
postoperative death or failure necessitating takedown
of the Fontan conduit.4,7,13 We therefore make every
effort to limit or avoid the use of cardioplegic arrest and
to shorten the duration of CPB at the time of the Fontan
operation. This is accomplished by performing most
ancillary intracardiac procedures (such as atrial septec-
tomy, valve repair, relief of outflow tract obstruction)
during the Glenn operation. This ensures that the
Fontan operation is limited to placement of the extra-
cardiac conduit alone (along with pulmonary arterio-
plasty, if necessary). Over the course of our experience,
we have become more adamant in this respect, which is
reflected by the fact that only 10% of our patients
underwent a concomitant intracardiac procedure, all of
whom were among the first 25 patients in this series.
In addition to these preoperative strategies, intraopera-
tive and technical features of the extracardiac Fontan
procedure offer advantages for preserving ventricular
and pulmonary vascular function. The operation is per-
formed entirely as an extracardiac procedure without the
use of cardioplegic arrest. Aortic crossclamping was not
used in 78% of our patients and in only 1 of our last 30
patients. In patients who do not require extensive pul-
monary arterioplasty, CPB time can be reduced by per-
forming the pulmonary anastomosis off bypass. Over the
course of our experience we have seen our CPB times
decrease significantly, and recently we have achieved
CPB times as low as 9 minutes (data not included in the
current series). At an extreme, the extracardiac Fontan
operation can be performed entirely without CPB, as
reported by Burke and associates.14 We have recently
experimented with this technique and believe it is a
viable alternative in appropriate candidates.15
Because we do not have an internal control group of
patients undergoing Fontan completion with other
techniques, we cannot determine whether the extracar-
diac conduit technique confers an early survival bene-
fit. Although the low failure rate prevented assessment
of factors associated with death or Fontan takedown,
our analysis did reveal several interesting findings
relating to postoperative hemodynamics and resource
use. Fontan pressure was significantly higher in
patients who required prolonged inotropic support,
prolonged stay in the intensive care unit, and prolonged
hospitalization. The strongest predictor of prolonged
inotropic and ventilatory support, factors that may be
considered markers of cardiopulmonary dysfunction,
was longer duration of CPB. This lends support to our
contention that the shorter duration of CPB required for
the extracardiac Fontan operation may help optimize
early postoperative outcome.
The ability to perform the extracardiac Fontan oper-
ation without the need to enter the heart poses a new
question regarding the role of routine fenestration. We
acknowledge that improved results have been reported
using fenestration with the lateral tunnel Fontan opera-
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tion.4,16,17 In this setting, the purpose of the fenestration
is to optimize Fontan hemodynamics in the early post-
operative period. Inasmuch as most of our patients
undergo the Fontan operation without cardioplegic
arrest and with a short duration of partial CPB, their
postbypass Fontan hemodynamics may be more favor-
able than those of patients who undergo the lateral tun-
nel operation without a fenestration. 
We have therefore refrained from routine fenestra-
tion, instead concentrating on performing fenestration
only in those patients who demonstrated objective evi-
dence of poor or marginal postpump hemodynamics.
This approach is especially suitable with the extracar-
diac technique, because the fenestration can be conve-
niently performed as a closed procedure without
resuming CPB, either in the operating room or in the
intensive care unit. By limiting fenestration to those
patients who will derive a hemodynamic benefit from a
postoperative right-to-left shunt, we hope to avoid the
potential morbidities associated with fenestration,
including systemic desaturation, systemic emboliza-
tion, and the need for an additional procedure to close
the fenestration. Overall, we have performed fenestra-
tion in about half of our patients, and with improve-
ments in our perioperative strategies for preserving
ventricular and pulmonary vascular function, we have
seen the incidence of fenestration decrease significant-
ly over time (from 65% in the first 31 patients to 20%
in the last 20 patients). 
One of the most promising advantages of the extra-
cardiac Fontan operation may be its potential to reduce
supraventricular arrhythmias, which are a persistent
source of morbidity and mortality after the Fontan oper-
ation.18-22 The extracardiac conduit approach avoids or
minimizes all 4 of the factors thought to be important
potential contributors to arrhythmias after the Fontan
procedure: (1) exposure of the right atrium to the ele-
vated systemic venous pressure, (2) extensive atrial inci-
sions and suture lines,23 (3) surgery in the vicinity of the
sinus node,22 and (4) ventricular dysfunction resulting
from ischemic arrest and long CPB times. 
New-onset transient supraventricular tachyarrhyth-
mias occurred in 10% of our patients in the early post-
operative period. Most of these were either extremely
short-lived (<10 minutes), or they occurred within the
first 48 hours after the operation when the patients were
under the influence of endogenous (pain) and exoge-
nous (inotropic agents) catecholamines. None of the
patients were discharged on a program of antiarrhyth-
mia medication. Transient sinus node dysfunction
occurred in 8% of the patients in the early postoperative
period. Most of these episodes resolved within 48 hours
after the operation, and none of the patients required a
permanent pacemaker at the time of discharge. The fig-
ures above compare favorably with the 14% to 32%
incidence of atrial arrhythmias (including supra-
ventricular tachycardia and sinus node dysfunction)
reported recently for other types of Fontan opera-
tion.3,7,21,22 Moreover, late atrial rhythm abnormalities
occurred in only 2 patients at a median follow-up time
of 1.9 years. Although these results are encouraging,
longer follow-up will be necessary to confirm the
advantages of the extracardiac approach in decreasing
the incidence of late postoperative atrial arrhythmias. 
Another feature of the extracardiac conduit approach
that may play a role in improving early postoperative
outcome is the improved laminar flow patterns, which
can theoretically be achieved in the Fontan circuit. The
importance of avoiding turbulence and stasis has been
demonstrated convincingly by hydrodynamic and com-
putational modeling studies.24-26 The extracardiac
Fontan conduit is made of a smoothly contoured cir-
cumferential tube that can potentially optimize flow
dynamics. The conduit can also be conveniently incor-
porated into a pulmonary arterioplasty both medially
toward the pulmonary trunk and laterally toward the
right lower lobe pulmonary artery. Clinical and experi-
mental hydrodynamic and imaging studies will be nec-
essary to validate the hemodynamic advantages of the
extracardiac Fontan operation.
Median duration of chest tube drainage was 8 days,
and prolonged drainage (more than 2 weeks) occurred
in 21% of the patients. These figures are similar to the
13% to 39% incidence of prolonged drainage reported
recently for other types of Fontan operation.3,4,6,16,17
Our approach to removing chest tubes in patients who
undergo a Fontan operation is extremely conservative.
Chest tubes are not removed unless the drainage is less
than 1 mL/kg per day for at least 2 days. Although this
approach prolongs the time before chest tubes are
removed, it decreases the incidence of readmission for
recurrent effusions (only 2 patients in our series). We
recognize the reported role of fenestration in decreas-
ing postoperative effusions4; however, because we have
no control group, we cannot draw inferences regarding
the need for fenestration on the basis of our effusion
data. Our analysis nonetheless did not show any signif-
icant difference in the duration of chest tube drainage
between patients with and without fenestration. 
The extracardiac Fontan operation has potential dis-
advantages that relate to the use of a conduit, including
lack of growth potential, conduit stenosis, and throm-
boembolism. By waiting until the patient weighs at
least 15 kg (approximately 3 years of age) before per-
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forming the operation, we expect to avoid reoperation
by using an adult-sized conduit (20-22 mm), which
should accommodate the patient’s future growth and
exercise demands. None of our patients has had evi-
dence of conduit stenosis or obstruction, but we never-
theless recommend periodic imaging to monitor con-
duit patency. In view of the reported 18% to 20% risk
of postoperative thromboembolism after different types
of Fontan procedures,27,28 a majority of our patients
were discharged from the hospital on a regimen of
acetylsalicylic acid or warfarin. Our current recom-
mendation is warfarin therapy for the first 3 postopera-
tive months and acetylsalicylic acid thereafter. 
In conclusion, our approach to the extracardiac con-
duit Fontan operation has evolved over the course of
our experience. With a strategy that centers increasing-
ly on preservation of ventricular and pulmonary vascu-
lar function, in both the preoperative and intraoperative
periods, we have been able to perform the operation
with minimal early postoperative morbidity and mor-
tality. By avoiding concomitant intracardiac proce-
dures, we have seen our CPB times decrease, our inci-
dence of aortic crossclamping and fenestration decline,
and many of the potential advantages of the extracar-
diac approach realized. Long-term benefits of the
extracardiac conduit Fontan operation remain to be
determined in future follow-up studies. 
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Commentary
The original description of the Fontan procedure
included placement of an extracardiac conduit from the
right atrium to the left pulmonary artery. When Fontan
and Kirklin1 reviewed the late outcome of an early
cohort of patients surviving the Fontan procedure, they
concluded that much of the late morbidity could be
attributed to problems associated with conduit use.
Why is it, then, that Petrossian and associates, as well
as other groups, are once again promoting use of an
extracardiac conduit for this procedure?
Petrossian and others argue that the technique of con-
duit insertion originally described by Fontan involved
anterior placement of a valved homograft that was sub-
ject to compression by the sternum, as well as calcifi-
cation of the homograft valve. They believe that a non-
valved polytetrafluoroethylene conduit will be less
likely to become obstructed, both because of its poste-
rior location in the mediastinum and because of the
nature of the conduit itself.
It is the hope of those promoting the conduit tech-
nique that by not exposing any atrial tissue to high
pressure and by markedly reducing the atrial suture
load, they can reduce the late incidence of atrial flutter.
Flutter has emerged as probably the most common late
complication after the Fontan procedure in the present
era. Predisposing factors include the high pressure to
which the wall of the systemic venous chamber is
exposed with the lateral tunnel and other nonconduit
techniques. Furthermore, Rodefeld and coworkers2
have demonstrated in an animal model that the lateral
tunnel technique predisposes to flutter through its dis-
tribution of suture load in critical areas.
Another theoretic advantage of the extracardiac con-
duit in performing the Fontan procedure is that it can be
done with a shorter crossclamp time or possibly no
myocardial ischemia. Petrossian and associates suggest
that this will reduce the need for fenestration and the
incidence and duration of pleural effusions. Median
duration of chest tube drainage in their series of 51
patients was 8 days, with 21% of their patients having
prolonged drainage of greater than 2 weeks. Median
hospital stay was 13 days.
Not all groups have accepted the current enthusiasm
for routinely applying a conduit in performing the
Fontan procedure. Certainly justification must be pro-
vided for any procedure in growing children that vio-
lates the fundamental principle of incorporating growth
potential in the design of a congenital cardiac repair.
There are other serious concerns that must be carefully
assessed before this approach is embraced widely.
Apart from atrial flutter, other late complications of the
Fontan procedure include the development of cirrhosis3
and protein-losing enteropathy.4 These problems surely
have some relation to the cumulative impact of raised
systemic venous pressure. Thus even an apparently
functionally insignificant gradient of 2 or 3 mm Hg
across a conduit over many years is likely to increase
the probability of development of these very serious
untreatable complications (unlike atrial flutter, for
which a number of treatment options are available).
Petrossian and colleagues suggest that the age at which
the Fontan procedure should be performed should be
increased to reduce the probability that conduit
replacement will be necessary.
Other studies have suggested that there is an
increased thrombotic tendency in patients after the
Fontan procedure.5 This risk has led most groups to
institute at least aspirin therapy, and some are even rec-
ommending permanent warfarin sodium (Coumadin)
treatment. Prosthetic material in human beings rarely
becomes endothelialized beyond the first 5 to 10 mm.
Although this may permit full endothelialization of a
baffle as is used in the lateral tunnel technique, it
means that a complete conduit will never become fully
endothelialized. In the setting of a prothombotic state,
this may increase the risk of multiple pulmonary
emboli and, if a fenestration is placed, systemic emboli.
On the other hand, proponents of the conduit technique
can rightfully argue that the lateral tunnel technique
places a large amount of prosthetic material in the pul-
monary venous atrium with therefore an increased risk
of systemic emboli.
It remains unclear from the study by Petrossian and
coworkers whether the reduction in myocardial
ischemia afforded by the conduit technique does truly
reduce the need for fenestration. A recent review of 55
consecutive patients having Fontan procedures be-
tween October 1997 and September 1998 at Children’s
Hospital, Boston (unpublished data), revealed a medi-
an duration of hospitalization (including the day of
surgery) of 9 days versus 13 days in the Petrossian
series. Only 5 of 55 patients (9%) in the Boston series
had pleural effusions in excess of 2 weeks versus 21%
in Petrossian’s series. One patient in Petrossian’s series
died at reoperation for attempted late placement of a
fenestration. Previous analyses of the Fontan experi-
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ence in Boston have not identified fenestration place-
ment as being associated with an increased risk of neu-
rologic injury either early or late. Most fenestrations
will probably close spontaneously over a year or two if
allowed. Alternatively, they can be closed in the
catheterization laboratory a year or so after the opera-
tion when appropriate hemodynamics are demonstrat-
ed by temporary balloon occlusion.
Many questions remain unanswered about both the
optimal technique and optimal staging and timing of
the Fontan procedure in the palliation of single ventri-
cle.6 It is important that information now be collected
carefully, ideally as a randomized prospective trial, to
demonstrate that the advantages of the conduit tech-
nique outweigh its many potential disadvantages
before the technique is more widely applied.
Richard A. Jonas, MD
Boston, Massachusetts
R E F E R E N C E S
1. Fontan F, Kirklin JW. Outcome after a perfect Fontan operation.
Circulation 1990;81:1520-36.
2. Rodefeld MD, Bromberg BI, Schuessler RB, Boineau JP, Cox JL,
Huddleston CB. Atrial flutter after lateral tunnel construction in
the modified Fontan operation: a canine model. J Thorac Cardio-
vasc Surg 1996;111:514-25.
3. Lemmer JH, Coran AG, Behrendt DM, Heidelberger KP, Stern
AM. Liver fibrosis (cardiac cirrhosis) five years after modified
Fontan operation for tricuspid atresia. J Thorac Cardiovasc Surg
1983;86:757-60.
4. Feldt RH, Driscoll DJ, Offord KP, Cha RH, Perrault J, Schaff HV,
et al. Protein-losing enteropathy before and after the Fontan oper-
ation. J Thorac Cardiovasc Surg 1996;112:672-80.
5. Jahangiri M, Ross DB, Redington AN, Lincoln C, Shinebourne
EA. Thromboembolism after the Fontan procedure and its modi-
fications. Ann Thorac Surg 1994;58:1409-14.
6. Jonas RA. Indications and timing of the bidirectional Glenn shunt
versus the fenestrated Fontan circulation. J Thorac Cardiovasc
Surg 1994;108:522-4.
12/1/97053
